Study finds over 100 value-based contracts

Despite legal barriers and practical obstacles, over 100 value-based contracts were negotiated between drug manufacturers and payers from 2014 to 2017, according to

Read the full 231 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE